Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?

Published 15/12/2022, 22:23
© Reuters.  After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
EXAS
-
GH
-

Benzinga - Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.

What To Know: Guardant Health shares are plunging after the company announced results from its ECLIPSE study evaluating the performance of its blood test for detecting colorectal cancer.

The test demonstrated 83% sensitivity in detecting individuals with colorectal cancer. Specificity was 90% in both individuals without advanced neoplasia and in those who had a negative colonoscopy result.

Exact Sciences owns Cologuard, a stool-based cancer test that would directly compete with Guardant Health's blood test. Cologuard is FDA approved and identifies 92% of colorectal cancers, according to data from the company.

From Last Month: After Bill Gates Dumps Billions In Berkshire To Buy Microsoft (NASDAQ:MSFT), His Quiet Biotech Portfolio Has Made A New Trade

GH, EXAS Price Action: Guardant Health shares are down 40.6% in after hours at $24.50, while Exact Sciences shares are up 25.8% at $56.10, according to Benzinga Pro.

Photo: fernando zhiminaicela from Pixabay.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.